Skip to main content

Table 2 Oral 75 g glucose tolerance test results and C-peptide and insulin release results

From: Rare, late onset of immune checkpoint inhibitor-induced type 1 diabetes mellitus in a patient with small-cell lung cancer treated with serplulimab: a case report and review of the literature

Measurement time (min)

Glucose (mmol/L)

C-Peptide (ng/mL)

Insulin (mIU/L)

0

4.84

 < 0.03

 < 1.00

30

6.47

 < 0.03

 < 1.00

60

12.84

 < 0.03

 < 1.00

120

18.43

 < 0.03

 < 1.00